clinical validation

Aerodigestive Health Corporation (AHC) is a One Health-focused, integrated medtech and biotech startup headquartered in Overland Park, Kansas, advancing aerodigestive health through innovations and consumables for humans and animals. It originated from Lever Scientific LLC (established 2013) and was incorporated as a Delaware C Corporation in 2023. AHC develops diagnostic tools, non-invasive devices, and new treatments for swallowing, speech, and breathing disorders.

diagnostic platform developmentdirect salesnon-invasive device developmentsublicensingtechnology development and clinical translation

AIQ Solutions is a group of entrepreneurs, scientists, and engineers with a vision to improve treatment outcomes for patients with a wide range of complex diseases. The company develops software medical devices, including TRAQinform IQ, which provides novel information about quantification of change in regions of interest over time, enabling oncologists to more precisely adjust therapies and optimize clinical outcomes for late-stage cancer care.

quantitative imaging analysissoftware medical device development

Asher Orion Group provides consulting services for healthcare organizations and AI vendors, helping them determine the right medical AI strategy and optimize execution to deliver clinical value. The company assists AI vendors in focusing on the right solution and reaching the right markets and customers faster, with expertise spanning technology, product management, regulatory, and market strategy across the healthcare ecosystem.

AI value quantificationalgorithm lifecycle managementcommercial AI assessmentevidence creationmedical AI strategy consultingproduct managementregulatory strategytechnology roadmap planningtechnology scouting

Bezyl is an intelligence infrastructure for mental health innovation that connects the development of trusted mental health innovation with its real-world deployment. It helps mental health innovations succeed through investor networking, validation, partnerships, and global deployment, and helps organizations build healthier communities through curated toolboxes, continuous engagement, and measurable outcomes. Founded by Esther Howard, Bezyl operates across Israel, the United States, and Canada.

commercializationfunding strategyglobal deploymentinvestor networkingmarket strategypartnershipsvalidation

Click Therapeutics is redefining modern medicine with patient-centric digital treatments. Operating at the intersection of biology and technology, Click combines neuroscience with the power of software, creating a new way to treat disease. The company develops, validates, and commercialize software as prescription medical treatments for people with unmet medical needs. Founded in 2012 by David Benshoof Klein, who created the term Digital Therapeutics™.

AI-enabled platformcommercialization of prescription digital therapeuticsneuromodulatory mechanisms of actionpharmacotherapy combinationsoftware development

DxNexis Consulting is a laboratory strategy consulting firm that partners with governments, donors, and private sector stakeholders to advance equitable laboratory systems in low- and middle-income countries. It specializes in laboratory systems strategies, diagnostic network optimization, procurement strategies, supply chain strategies, and integrated solutions for diagnostics development, regulatory compliance, and global health program support.

analytical sciencesdiagnostic network optimizationlab capacity buildinglaboratory network strategyprocurement strategyquality systems (ISO, GLP)regulatory submissions (WHO, FDA)risk managementsupply chain strategytraining

EarlyMobility.com provides expert Program Management and consulting services focused on Early Mobility and Safe Patient Mobility™ practices, helping facilities build a foundation on culture change. What started as a free early mobility resource page by Margaret Arnold (now CEO) has become a company offering consulting services and early mobility program development and management, with a team assembled with 100+ years of consulting experience.

clinical trainingconsultingeducational material reviewprogram managementworkshops

Management Team Reza Shekarriz, Founder/CEO Entrepreneur and visionary, leading tech development in several companies with demonstrated hands-on skills in management and leadership 25 Years of experience in product-driven R&D within private and national lab environment, with over 100 publications/reports and patents Innovative microfluidic, acoustofluidic, optoelectronic, and electrohydrodynamic sample prep and sensing products launch and commercialization Expertise in small business launch, growth, and exit PhD in Mechanical Engineering from WSU and post-doc at the Johns Hopkins University Reza Shekarriz, Founder/CEO Entrepreneur and visionary, leading tech development in several companies with demonstrated hands-on skills in management and leadership 25 Years of experience in product-driven R&D within private and national lab environment, with over 100 publications/reports and patents.

electrolytic H2S synthesis and deliverymedical device R&Dmicroelectronic devicesmicrofluidicstrace-level gas sensing

Fujirebio is an R&D-driven in vitro diagnostics (IVD) company that develops biomarkers and diagnostic technologies, from research and clinical validation on its Lumipulse platform to global sharing through CDMO partnerships. It provides diagnostic raw materials, reagents, instruments, kits, software, and controls, and offers development, manufacturing, and clinical and regulatory services to partners.

CDMO servicesmanufacturingR&Dregulatory services

FYR Bio is a precision medicine company whose EV-Omics (EVO) platform uses AI-enabled multi-omic insights to profile extracellular vesicles (EVs) in blood, decoding RNA and protein signals to support biomarkers, clinical trials, diagnostics, and drug development. Its proprietary SPARCs technology enriches disease-associated EVs to improve signal-to-noise. The company partners on study design, custom data outputs, and clinical validation across diagnostics, drug development, and precision medicine.

AI-enabled multi-omic insightsbiomarker discoveryCLIA laboratory testingextracellular vesicle profilingliquid biopsyRNA and protein analysis

Hippocratic AI builds generative AI healthcare agents (clinical voice AI) for health systems, payors, and pharmaceutical/life sciences companies. Its agents do not diagnose or prescribe, and the company reports over 180 million clinical interactions across 1,000+ use cases with 60+ partners. Its agents are built on the Polaris 5.0 constellation architecture and clinically validated with a network of over 7.7K US licensed clinicians on over 775K test calls.

acoustic bio-marker cough detectionclinical voice AIgenerative AI healthcare agentsmedication reconciliationmulti-call memorysymptom detection and escalation to live RN

IDX20 is a first-responder diagnostic company focused on faster and more accurate diagnoses and better healthcare outcomes. Its assays provide instant, highly accurate results, and a mobile tracking app delivers data in real-time. The company designs and deploys diagnostic technologies as comprehensive start-to-end solutions, aiming to create a new generation of rapid diagnostics for detecting pathogens with pandemic potential.

antigen test validationdata collection and analysisdiagnostic technology designlaboratory analysis